Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Osteoclast-like Cells in Early Zebrafish Embryos.

Sharif F, de Bakker MA, Richardson MK.

Cell J. 2014 Summer;16(2):211-24. Epub 2014 May 25.

2.

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.

Bone. 2005 Jan;36(1):159-72. Epub 2004 Nov 24.

PMID:
15664014
3.

Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.

Zenger S, Hollberg K, Ljusberg J, Norgård M, Ek-Rylander B, Kiviranta R, Andersson G.

Bone. 2007 Nov;41(5):820-32. Epub 2007 Jul 19.

PMID:
17765026
4.

Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes.

Chia LY, Walsh NC, Martin TJ, Sims NA.

Bone. 2015 Mar;72:34-42. doi: 10.1016/j.bone.2014.11.005. Epub 2014 Nov 15.

PMID:
25460578
5.

Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis.

Kozawa E, Nishida Y, Cheng XW, Urakawa H, Arai E, Futamura N, Shi GP, Kuzuya M, Hu L, Sasaki T, Ishiguro N.

Arthritis Rheum. 2012 Feb;64(2):454-64. doi: 10.1002/art.33398.

6.

Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.

Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N.

Comp Biochem Physiol A Mol Integr Physiol. 2013 Sep;166(1):74-80. doi: 10.1016/j.cbpa.2013.04.023. Epub 2013 Apr 28.

PMID:
23632157
7.

Effects of 10-hydroxycamptothecin on differentiation of RAW264.7 cells into osteoclasts.

Zhang M, Wang Y, Sun XL, Ren LL, Zhang LJ, Lu HQ.

J Biol Regul Homeost Agents. 2016 Jul-Sep;30(3):789-794.

PMID:
27655499
8.
9.

Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts.

Khan UA, Hashimi SM, Khan S, Quan J, Bakr MM, Forwood MR, Morrison NM.

J Cell Biochem. 2014 Jul;115(7):1290-8. doi: 10.1002/jcb.24781.

PMID:
24500983
10.

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R.

J Clin Invest. 2013 Feb;123(2):666-81. doi: 10.1172/JCI64840. Epub 2013 Jan 16.

11.

Osteoclasts are not activated in middle ear cholesteatoma.

Koizumi H, Suzuki H, Ikezaki S, Ohbuchi T, Hashida K, Sakai A.

J Bone Miner Metab. 2016 Mar;34(2):193-200. doi: 10.1007/s00774-015-0655-5. Epub 2015 Mar 22.

PMID:
25796629
12.

IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.

Kitami S, Tanaka H, Kawato T, Tanabe N, Katono-Tani T, Zhang F, Suzuki N, Yonehara Y, Maeno M.

Biochimie. 2010 Apr;92(4):398-404. doi: 10.1016/j.biochi.2009.12.011. Epub 2010 Jan 4.

PMID:
20045440
14.

Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.

Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX.

Cell Physiol Biochem. 2012;30(1):123-36. doi: 10.1159/000339052. Epub 2012 Jan 8.

15.

Regulation and Biological Significance of Formation of Osteoclasts and Foreign Body Giant Cells in an Extraskeletal Implantation Model.

Ahmed GJ, Tatsukawa E, Morishita K, Shibata Y, Suehiro F, Kamitakahara M, Yokoi T, Koji T, Umeda M, Nishimura M, Ikeda T.

Acta Histochem Cytochem. 2016 Jun 28;49(3):97-107. doi: 10.1267/ahc.16007. Epub 2016 Jun 16.

16.

Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.

Sharma SM, Sif S, Ostrowski MC, Sankar U.

J Cell Physiol. 2009 Jul;220(1):230-7. doi: 10.1002/jcp.21755.

17.

Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.

Vääräniemi J, Halleen JM, Kaarlonen K, Ylipahkala H, Alatalo SL, Andersson G, Kaija H, Vihko P, Väänänen HK.

J Bone Miner Res. 2004 Sep;19(9):1432-40. Epub 2004 Jun 14.

18.

Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.

Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR.

Arthritis Rheum. 2000 Feb;43(2):250-8.

19.

AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.

Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR.

Gene. 2007 Nov 15;403(1-2):151-8. Epub 2007 Aug 25.

PMID:
17897792
20.

Increased osteoclast activity is associated with aggressiveness of osteosarcoma.

Avnet S, Longhi A, Salerno M, Halleen JM, Perut F, Granchi D, Ferrari S, Bertoni F, Giunti A, Baldini N.

Int J Oncol. 2008 Dec;33(6):1231-8.

PMID:
19020756

Supplemental Content

Support Center